Japanese Earnings Roundup: Eisai's Accelerated Perampanel Development Hits The Brakes; Takeda Averts Actos Setbacks For Now

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.